Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




International Remote Imaging Plans Name Change

By HospiMedica staff writers
Posted on 08 Oct 2003
Assuming the required shareholder approval is received, International Remote Imaging Systems, Inc. More...
(IRIS, Chatsworth, CA, USA) will change its name to IRIS International, Inc., according to a company announcement.

IRIS is a manufacturer and marketer of automated in vitro diagnostic urinalysis systems and medical devices for hospitals and clinical laboratories. The company recently introduced its new IQ 200 system, a fully automated urine chemistry and microscopic analyzer. IRIS has a worldwide network of distributors covering 18 countries and has established a European subsidiary. The company's Iris Diagnostics Division is prominent in automated urinalysis technology, with workstations in major medical institutions throughout the world, and its patented technology and recognition software have made significant reductions in the cost and time required for manual microscopic analysis.

"With a new flagship product, updated manufacturing facilities, and new customers around the world, it is appropriate that the company has a new name,” said Dr. Kshitij Mohan, CEO. "It will further strengthen our brand and recognition among our customers and within the investment community.” IRIS has two subsidiaries, StatSpin (sample preparation for blood analysis products, Norwood, MA, USA) and Advanced Digital Imaging Research (proprietary imaging research, Houston, TX, USA).




Related Links:
IRIS

Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automatic Hematology Analyzer
DH-800 Series
Capillary Blood Collection Tube
IMPROMINI M3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.